Iron Metabolism Disorders
"Iron Metabolism Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)
| Descriptor ID |
D019189
|
| MeSH Number(s) |
C18.452.565
|
| Concept/Terms |
Iron Metabolism Disorders- Iron Metabolism Disorders
- Disorder, Iron Metabolism
- Disorders, Iron Metabolism
- Iron Metabolism Disorder
- Metabolism Disorder, Iron
- Metabolism Disorders, Iron
|
Below are MeSH descriptors whose meaning is more general than "Iron Metabolism Disorders".
Below are MeSH descriptors whose meaning is more specific than "Iron Metabolism Disorders".
This graph shows the total number of publications written about "Iron Metabolism Disorders" by people in this website by year, and whether "Iron Metabolism Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iron Metabolism Disorders" by people in Profiles.
-
Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med. 2012 Jan 26; 366(4):348-59.
-
Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011 Dec; 57(12):1650-69.
-
Miyazaki T, Kirino Y, Takeno M, Hama M, Ushihama A, Watanabe R, Takase K, Tachibana T, Matsumoto K, Tanaka M, Yamaji S, Ideguchi H, Tomita N, Fujita H, Ohno S, Ueda A, Ishigatsubo Y. Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol. 2010 Mar; 91(2):229-37.
-
Lesnikov V, Gorden N, Fausto N, Spaulding E, Campbell J, Shulman H, Fleming RE, Deeg HJ. Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2. Apoptosis. 2008 Aug; 13(8):1005-12.
-
Regan RF, Chen M, Li Z, Zhang X, Benvenisti-Zarom L, Chen-Roetling J. Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin. Neurobiol Dis. 2008 Aug; 31(2):242-9.
-
Sirover WD, Siddiqui AA, Benz RL. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. Ren Fail. 2008; 30(9):884-9.
-
Brooks DG, Manova-Todorova K, Farmer J, Lobmayr L, Wilson RB, Eagle RC, St Pierre TG, Stambolian D. Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. Invest Ophthalmol Vis Sci. 2002 Apr; 43(4):1121-6.